Skip to main content

Table 7 The genetic causes related to postovarian female infertility: from the first observation to the report

From: The evolving role of genetic tests in reproductive medicine

Indications for genetic test

Genetic disorder

Frequency

Genetic test

Genetic alterations

ART

Inheritance

Antenatal test

Differential diagnosis

Refs.

Underdeveloped or absent uterus and abnormalities of other reproductive organs; normal female external genitalia, breasts; hyperandrogenism; facial hirsutism; primary amenorrhea; infertility

Müllerian aplasia and hyperandrogenism (other names: Biason–Lauber syndrome, WNT4 deficiency)

Rare

Molecular diagnosis

WNT4 gene

NA

AD or de novo

✓

Abnormalities of the reproductive system

[97,98,99]

Vagina and uterus to be underdeveloped or absent, although external genitalia are normal, primary amenorrhea

Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome (type 1)

1 in 4500

Molecular diagnosis

ESR1, OXTR, WNT9B

NA

AD

✓

Abnormalities of the reproductive system

[100,101,102]

Underdeveloped or absent vagina and uterus, although external genitalia are normal; primary amenorrhea; unilateral renal agenesis; skeletal abnormalities; hearing loss or heart defects

Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome (type 2)

Bone marrow failure, hypopigmentation, short stature, physical abnormalities, organ defects (gastrointestinal abnormalities; heart defects; eye abnormalities, malformed ears and hearing loss), and an increased risk of certain cancers; abnormal genitalia or malformations of the reproductive system and infertility

Fanconi anemia (Fanconi pancytopenia

Fanconi panmyelopathy)

1 in 160,000 (more common among people of Ashkenazi Jewish descent, the Roma population of Spain, and black South Africans)

Molecular diagnosis

FANCA, FANCC and FANCG (90%)

NA

AR; AD (RAD51-related FA); X-linked (FANCB-related FA).

✓

Bloom syndrome; ataxia–telangiectasia, Nijmegen breakage syndrome (NBS); Seckel syndrome; neurofibromatosis 1; POI

[62, 63]

  1. Database sources: NIH, OMIM and OrphaNet
  2. ✓, yes; ✗, no; NA, not applicable; POI, primary ovarian insufficiency